`

Stemedica Cell Technologies, Inc

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$22.0M
size-icon Size
11 - 50

Frequently Asked Questions About Stemedica Cell Technologies, Inc

What does Stemedica cell technologies, inc do?+

Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary manufacturing technology platform that produces allogeneic progenitor cell products with intellectual property protection under a low-oxygen, low-tension environment in a cGMP-compliant manufacturing facility. The companys lead drug candidate, ischemia-tolerant mesenchymal stem cells, or itMSCs, is an allogeneic progenitor cell therapy currently in clinical development for the treatment of ischemic stroke and Alzheimers disease. The companys second drug candidate, ischemia-tolerant neural progenitor cells, or itNSCs, is an allogeneic cell therapy currently...

What is Stemedica cell technologies, inc's industry? +

Stemedica cell technologies, inc operates in the Biotechnology research industry.

What is Stemedica cell technologies, inc's revenue? +

Stemedica cell technologies, inc's revenue is 11m - 100m

What is Stemedica cell technologies, inc's company size? +

Stemedica cell technologies, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.